Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06897137 · ClinicalTrials.gov registry record
Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- 3,000
- Enrollment target
NCT06897137: Recruiting study, sponsored by Wake Forest University Health Sciences.
NCT06897137 is a clinical trial that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06897137 is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
Study Summary
This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions
Primary Outcome
Upon completion of data analysis and study team review, investigators will have four unidimensional and locally independent, calibrated item banks: three for AYAs (body image, fertility, and financial burden) and one for caregivers (financial burden). In order to successfully calibrate an item bank, an n=500 is required per bank. In order to examine differential item functioning (DIF), a minimum n=200 per group is recommended. Our proposed sample sizes and specific subgroup accrual targets will
Interventions
- OTHER Surveys/Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2026-04-26 |
| Est. Completion | 2028-01 |
What NCT06897137 shows while recruiting
NCT06897137 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Surveys/Questionnaires is the first listed.
NCT06897137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06897137 about?
NCT06897137 is a clinical study titled "Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology". This study evaluates how adolescent and young adults with cancer in the U.S. and their loved ones respond to questions that will later be used with people who may have cancer and other chronic health conditions
What is the current status of trial NCT06897137?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2026-04-26. Estimated completion is 2028-01.
What interventions are being tested in trial NCT06897137?
The interventions under investigation include: Surveys/Questionnaires (OTHER).
Who is sponsoring clinical trial NCT06897137?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI